Hidradenitis suppurativa is a chronic inflammatory disorder involving the apocrine sweat glands of the axilla, perineum, and breast. It is thought that a defect in the epithelial lining of the hair follicle is followed by secondary bacterial infection and local tissue inflammation. Treatment poses a unique challenge because of the recurrent nature of the disease. Many treatment options exist, although the best technique for preventing recurrence is surgical excision. 1 The surface pathology often represents the lesser disease, with a much more extensive subcutaneous network of sinuses, abscesses, and scarring. Therefore, wide local excision with removal of the entire portion of hairbearing skin is vital to complete correction. Inadequate excision leads to recurrence.
After excision, the defect may be closed by skin grafting, local flap reconstruction, secondary intention, or, in the following cases, using a biosynthetic dressing. Most methods can lead to scarring and limited range of motion and contour defects of the axilla or back.
Split-thickness skin grafting remains the standard procedure for closure, although it is associated with a degree of secondary contracture and donor-site morbidity. We suggest that Biobrane (Bertek, Morgantown, W. Va.) is a viable alternative to split-thickness skin grafting in select patient populations. 2 Flap closure has been well described and is subject to the surgical issues associated with flap procedures such as necrosis and flap loss. Cases of axillary contracture following such flap loss have been described. 3 The potential for scar extension to more visible areas must also be considered. The use of Biobrane, a biosynthetic skin substitute, has been well described in the treatment of burn wounds. 2 It is composed of a nylon mesh fabric mechanically embedded in a silicone membrane. Both components are then coated with porcine collagen peptides by chemical cross-linking, creating a hydrophilic and tissue-compatible dressing. 4 Experience with Biobrane in pediatric burn patients has shown decreased wound healing times, less pain, and shorter hospitalizations with a greater percentage of wound care administered on an outpatient basis. 5 African American women are most frequently plagued with this disease, and they are at high risk for unfavorable scarring. We present a series of patients with known predisposition to keloid formation for whom we prospectively used biosynthetic dressings to treat the axillary excision defects. The benefits and risks of Biobrane coverage after wide local excision of axillary hidradenitis are presented.
PATIENTS AND METHODS
We conducted a prospective review of four patients who presented with hidradenitis and failed nonoperative treatment. Each patient underwent wide local excision with Biobrane wound closure. All patients underwent outpatient surgery. The patients underwent excision to the level of the superficial axillary fascia, avoiding the axillary lymph node basin. Wounds were closed with Biobrane and absorb- 
CASE REPORTS

Case 1
A 38-year-old African American man with history of acne keloidalis nuchae of the posterior neck and scalp requiring excision and skin grafting presented with chronic, bilateral, severe axillary hidradenitis. He had previously taken a course of amoxicillin/clavulanate with no resolution. The patient underwent wide local excision measuring 20 ϫ 15 cm bilaterally, with Biobrane closure. The wound was cared for with wet-to-dry dressings initially. Two weeks postoperatively the wound was completely covered with granulation tissue and the Biobrane had fallen off. There were no signs of infection and the patient began 1% silver sulfadiazine cream dressings. Two months postoperatively the wounds were completely covered with granulation tissue, the patient was completely asymptomatic, and, importantly, he had 100 percent of his range of motion bilaterally (Fig. 1, above) . At 3 months, wound closure was confirmed and he had no restriction of motion. At 2-year follow-up the wound was well healed with no limitation in range of motion or strength (Fig. 1, below) .
Case 2
A 24-year-old morbidly obese African American woman presented with worsening painful, bilateral axillary hidradenitis. She had previously failed nonsurgical therapies (Fig. 2,  above) . She underwent a wide local excision removing 22 ϫ 20 cm of tissue bilaterally. The superior and inferior margins of the wound were closed primarily because of minimal tissue tension in these areas, leaving a final central defect of 10 cm (Fig. 2, below) . This portion was closed as described above using Biobrane (Fig. 3) . The postoperative course included 1% silver sulfadiazine cream dressing changes. Two weeks postoperatively the Biobrane was partially removed because of underlying granulation tissue, at which time the patient was asymptomatic Two months postoperatively the wounds were nearly healed and the patient had normal range of motion. At her most recent follow-up she was asymptomatic, her wounds were well healed, and she had normal abduction.
Our other two cases are summarized in Table I .
DISCUSSION
The treatment of hidradenitis suppurativa can be fraught with complications. The end result of the disease is a series of disfiguring scars, sinuses, and recurrent abscesses. The disease has been very resistant to conservative measures and tends to recur with limited local excision techniques.
Studies have compared the use of limited local excision, excision of all hair-bearing skin, and wide local excision. They have repeatedly found that the recurrence rate is lowest with wide excision. 1 The definitive excision leaves a significant defect that can produce a reconstructive challenge. These wounds are often colonized with bacteria, are large, and occur in patients with a high risk of scar formation and shoulder joint restriction.
Split-thickness skin grafting is the standard procedure; although it can lead to a good outcome, it is limited by a number of factors. A certain percentage of these cases eventually need contracture release. Second, the aesthetic result is often poor and leaves a distorted contour of the axilla with a "waffle" configuration. Third, grafting relies on the recipient site and subsequent graft "take" to be successful; this is not always a certainty considering the suboptimal tissue present following excision. A disadvantage that has not been well described and is more specific to our study population is the propensity for keloid formation. In these patients, the potential for keloid formation at the graft donor site makes this method much less acceptable.
Local advancement flaps are limited in the amount of surface they can cover and may not cover a large local excision. Flap closure has been shown in several studies to be superior to split-thickness skin grafting in regard to wound contracture. 6 Although some studies have described good aesthetic outcomes, there is potential for donor-site deformity and scarring and a poorly contoured axilla. Several of the described musculocutaneous flaps require the closure of the donor site by skin grafting.
Wound closure with a semiopen dressing, such as Biobrane, allows egress of bacteria and fluid from the wound while leading to epithelialization of the wound. Biobrane has also been shown to diminish wound contraction, possibly by inhibiting myofibroblast activity. 7, 8 An unexpected finding was the reported pain score after surgery. All patients reported significantly lower pain postoperatively as compared with preoperative pain scores.
Several studies have shown that there is no difference in the incidence of wound infection among patients treated with Biobrane and those treated with conservative treatment of topical antibiotics and dressing changes. 3 The advantage of Biobrane noticed at the end of our experience was that these patients had good skin healing, with minimal pain during dressing changes. The Biobrane dressing typically remained over the wound for 2 weeks, acting to stabilize the wound against pure contracture and providing a template for epithelial migration. Epithelialization progressed from wound margins, as all skin appendages were removed during excision. Wound closure with Biobrane has several disadvantages and advantages as compared with other closure modalities. The limitations include a longer healing time, a requirement for continuing wound care, and the cost of Biobrane (approximately $300 for a typical closure). The advantages include a single-stage procedure, no donor-site morbidity, and the ability to use Biobrane in colonized tissue. Furthermore, closure with Biobrane limits the need for deep axillary excision because, unlike split-thickness skin grafting, Biobrane does not require an adequate recipient bed for "take." Biobrane also acts as a matrix for granulation tissue formation.
The major limitation of this study is the small number of patients. Further study with more patients and comparisons of quantitative epithelialization times of Biobrane and splitthickness skin grafting would be beneficial.
SUMMARY
Hidradenitis suppurativa is a chronic inflammatory disorder involving the apocrine sweat glands of the axilla, perineum, and breast. Treatment poses a unique challenge because of the recurrent nature of the disease. Many treatment options exist, although the best technique for preventing recurrence is surgical excision. After excision, the defect may be closed by skin grafting, local flap reconstruction, or secondary intention. We used a biosynthetic dressing, Biobrane, as an alternative in patients with high-risk donor sites. Certain patient populations are poor candidates for split-thickness skin grafting because of a predilection for forming keloid in donor-site areas. The use of Biobrane eliminates this potential complication. Further advantages to using Biobrane include rapid re-epithelialization and wound healing, less patient discomfort, and less wound contraction compared with other techniques. We suggest that Biobrane is a viable alternative in select patient populations. The use of Biobrane and a rigorous postsurgical rehabilitation program successfully minimized wound contracture and maximized range of motion about the shoulder joint in our patients.
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